Genotypic analysis of the protease and reverse transcriptase of HIV type 1 isolates from recently infected injecting drug users in western China

AIDS Research and Human Retroviruses

Volumn 23, Issue 8, 2007, Pages 1062-1065

  Liao, Lingjie ^a   Xing, Hui ^a   Li, Xinping ^a   Ruan, Yuhua ^a   Zhang, Yuanzhi ^b   Qin, Guangming ^c   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Xinjiang Center for Disease Control and Prevention   (China)

^c SICHUAN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; POL PROTEIN; PROTEINASE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CHINA; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG ABUSE; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS TYPING;

ANTI-HIV AGENTS; CHINA; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34848838860     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0050     Document Type: Article

References (12)

1. Ministry of Health in China, UNAIDS and WHO: 2005 update on the HIV/AIDS epidemic and response in China. 2006, 1-10.
2. Shao Y, Zeng Y, Chen Z, et al.: Isolation of viruses from HIV infected individuals in Yunnan. Chin J Epidemiol 1991;12:129-135.
3. Wei M, Guan Q, Liang H, et al.: Simple subtyping assay for human immunodeficiency virus type 1 subtypes B, C, CRF01_AE, CRF07_BC, and CRF08-BC. J Clin Microbiol 2004;42:4261-4267.
4. Su L, Graf M, Zhang Y, et al.: Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B_) recombinant strain in China. J Virol 2000;74:11367-11376.
5. Zhong P, Kang L, Pan Q, et al.: Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance-associated mutations in Shanghai, P. R. China. J Acquir Immune Defic Syndr 2003;34:91-101.
6. Laeyendecker O, Zhang G, Quinn T, et al.: Molecular epidemiology of HIV-1 subtypes in southern China. J Acquir Immune Defic Syndr 2005;38:356-362.
7. Zhang FJ, Pan J, Yu L, et al.: Current progress of China's free ART program. Cell Res 2005;15:870-876.
8. Shafer RW, Warford A, Winters MA, et al.: Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals. J Virol Methods 2000;86:143-153.
9. Jiang SL, Xing H, Si XF, et al.: Polymorphism of the protease and reverse transcriptase and drug resistance mutation patterns of HIV-1 subtype B prevailing in China. J Acquir Immune Defic Syndr 2006;42:512-514.
10. van de Vijver DA, Wensing MJ, Angarano G, et al.: The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr 2006;41:352-360.
11. McClutchan FE, Carr JK, Murphy D, et al.: Precise mapping of recombination breakpoints suggests a common parent of two BC recombinant HIV type 1 strains circulating in China. AIDS Res Hum Retroviruses 2002;18:1135-1140.
12. Brenner B, Turner D, Oliveira M, et al.: A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. AIDS 2003;17:1-5.